{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T04:09:01Z","timestamp":1775966941056,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T00:00:00Z","timestamp":1348704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">RE<\/jats:styled-content>gistry of <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>ulmonary <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>ypertension <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ssociated with <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>heumatic <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>isease (<jats:styled-content style=\"fixed-case\">REOPARD<\/jats:styled-content>) was established in <jats:styled-content style=\"fixed-case\">K<\/jats:styled-content>orea. The baseline data are described from the second year of the registry's operation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with a connective tissue disease (<jats:styled-content style=\"fixed-case\">CTD<\/jats:styled-content>) who met the modified definition of the <jats:styled-content style=\"fixed-case\">WHO<\/jats:styled-content> group I pulmonary arterial hypertension (<jats:styled-content style=\"fixed-case\">PAH<\/jats:styled-content>) were enrolled. <jats:styled-content style=\"fixed-case\">PAH<\/jats:styled-content> was defined as a systolic pulmonary arterial pressure &gt;\u00a040\u00a0mmHg by echocardiography or mean pulmonary arterial pressure &gt;\u00a025\u00a0mmHg by right heart catheterization. Hemodynamic parameters and clinical data such as demographics, functional class, underlying disease, organ involvement, laboratory tests and current treatment were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 321 patients were enrolled during the 2\u2010year study period from 2008 to 2010. The mean age of the patients at registration was 51.9\u00a0years and 87.5% were female. Most patients were diagnosed by echocardiography and only 24 patients (7.5%) underwent cardiac catheterization. Exertional dyspnea was present in 63.6% of patients and 31.8% were <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>ew <jats:styled-content style=\"fixed-case\">Y<\/jats:styled-content>ork <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>eart <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ssociation class <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content> or <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content>. Among the patients, systemic lupus erythematosus accounted for 35.3%, systemic sclerosis 28.3%, rheumatoid arthritis 7.8%, overlap syndrome 9.0%, and mixed connective tissue disease 5.9%. There were no significant differences in hemodynamics, functional class, diffusing capacity and N\u2010terminal pro\u2010brain natriuretic peptide levels between the disease subgroups. Treatments consisted of calcium antagonists (57.0%), endothelin antagonists (32.7%), prostanoids (27.1%), phosphodiesterase\u20105 inhibitors (14.3%) and combinations (37.4%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Compared with previous studies, the results showed some differences: underlying diseases, functional status and treatments. This may be due to differences in ethnic background and diagnostic methods of our study.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1756-185x.2012.01815.x","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T18:28:30Z","timestamp":1348770510000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the <scp>K<\/scp>orean registry"],"prefix":"10.1111","volume":"15","author":[{"given":"Chan Hong","family":"Jeon","sequence":"first","affiliation":[{"name":"Department of Internal Medicine Soonchunhyang University Hospital Bucheon Bucheon Gyeonggi\u2010do Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u2010Young","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Bundang Jesaeng Hospital Seongnam Gyeonggi\u2010do Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young\u2010Il","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Hallym University Sacred Heart Hospital Anyang Gyeonggi\u2010do Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae\u2010Bum","family":"Jun","sequence":"additional","affiliation":[{"name":"Hanyang University Hospital for Rheumatic Diseases Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun\u2010Mi","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo\u2010Kon","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Department of Internal Medicine Institute for Immunology and Immunological Diseases Yonsei University College of Medicine Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.963983"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-216"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1668OC"},{"key":"e_1_2_7_6_1","first-page":"371","article-title":"Pulmonary hypertension in Switzerland: treatment and clinical course","volume":"138","author":"Fischler M","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.1.36"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2913"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-3008"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0260"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10442"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200806-953OC"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00092306"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00042107"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.10.989"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0206-5"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.898122"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780220403"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306072311"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-007-0569-8"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320109"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh253"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-007-0451-5"},{"issue":"5","key":"e_1_2_7_24_1","first-page":"591","article-title":"Diagnostics in pulmonary hypertension","volume":"58","author":"Schannwell CM","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.5.1313"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.8.865"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02964-9"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00074309"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9809-1"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11073"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2012.01815.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2012.01815.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:27:13Z","timestamp":1698780433000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2012.01815.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,27]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1111\/j.1756-185X.2012.01815.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2012.01815.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,27]]},"assertion":[{"value":"2012-09-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}